Infrared Thermography-based Study of the Warming Effect Difference at Waist

Launched by THE THIRD AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIVERSITY · Dec 22, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how different treatments for low back pain—specifically acupuncture and moxibustion (a form of heat therapy)—affect temperature changes in the lower back area. Low back pain is very common, and while many people experience it, treatments can sometimes have unwanted side effects. Acupuncture is a well-known option that has fewer side effects, and this study aims to compare its effectiveness against moxibustion at a specific acupuncture point called Weizhong.

To participate in this trial, you need to be between 18 and 60 years old, have a healthy body weight, and not have any history of lower back pain. You should also be able to move your back without restrictions. If you qualify and join the study, you’ll undergo treatments in a comfortable setting and have your back temperature measured afterward. This research could help us understand the best methods for treating low back pain and provide valuable insights into traditional acupuncture practices.

Gender

ALL

Eligibility criteria

• Inclusion criteria include:
• • 1. aged 18-60 (either sex);
• • 2. with a BMI of 18.5-23.9 kg/m2;
• • 3. with no history of lower back pain;
• • 4. with normal range of lumbar mobility (including flexion from 75-90 degrees, extension of 30 degrees, lateral bending from 20-35 degrees, and unilateral rotation of 90 degrees);
• • 5. willing to participate in the trial and have signed the informed consent form.
• Exclusion criteria:
• • 1. participants with serious heart, liver, kidney, or hematological diseases;
• • 2. women in menses, pregnancy, or lactation;
• • 3. those unable to complete the imaging in prone position (about 40 minutes);
• • 4. those with cognitive impairments;
• • 5. those with a history of lower back trauma or whiplash within a week;
• • 6. those with skin diseases or skin lesions, sensory impairments, scarring, or neoplasms at the test site;
• • 7. those with metal allergies
• • 8. those who have participated in other clinical trials that may affect the results of the study within the last three weeks.